CoChat

In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2

Open access

The DOI matches its Crossref record; 35 of the 37 references it cites were found in a registry or an index.

Abstract

Hepcidin is the principal iron-regulatory hormone and a pathogenic factor in anemia of inflammation. Patients with multiple myeloma (MM) frequently present with anemia. We showed that MM patients had increased serum hepcidin, which inversely correlated with hemoglobin, suggesting that hepcidin contributes to MM-related anemia. Searching for hepcidin-inducing cytokines in MM, we quantified the stimulation of hepcidin promoter-luciferase activity in HuH7 cells by MM sera. MM sera activated the hepcidin promoter significantly more than did normal sera. We then examined the role of bone morphogenetic proteins (BMPs) and interleukin-6 (IL-6), the major transcriptional regulators of hepcidin. Mutations in both BMP-responsive elements abrogated the activation dramatically, while mutations in the IL-6–responsive signal transducer and activator of transcription 3-binding site (STAT3-BS) had only a minor effect. Cotreatment with anti–BMP-2/4 or noggin-Fc blocked the promoter induction with all MM sera, anti–IL-6 blocked it with a minority of sera, whereas anti–BMP-4, -6, or -9 antibodies had no effect. BMP-2–immunodepleted MM sera had decreased promoter stimulatory capacity, and BMP-2 concentrations in MM sera were significantly higher than in normal sera. Our results demonstrate that BMP-2 is a major mediator of the hepcidin stimulatory activity of MM sera.

Overview

Integrity signals

Registry

Crossref · 10.1182/blood-2010-03-274571

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 35 references

Cited by

See all 132

Metadata

Authors
Maes, K., Nemeth, E., Roodman, G. D., Huston, A., Esteve, F., Freytes, C., Callander, N., Katodritou, E., Tussing-Humphreys, L., Rivera, S., Vanderkerken, K., Lichtenstein, A., & Ganz, T.
Affiliations
  • Vrije Universiteit Brussel (BE)
  • University of California, Los Angeles (US)
  • University of Pittsburgh (US)
  • University of Texas Health Science Center, Audie L. Murphy Memorial Veterans Hospital, San Antonio, TX;
  • University of Wisconsin–Madison (US)
  • Theageneio General Hospital (GR)
  • Agricultural Research Service (US)
Venue
Blood
Published
2010-11-04
Volume
116
Issue
18
Pages
3635-3644
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W1994912628
Cited by
132
References
37
Citations by year
2026: 2 · 2025: 5 · 2024: 5 · 2023: 6 · 2022: 5 · 2021: 8 · 2020: 3 · 2019: 3 · 2018: 4 · 2017: 12 · 2016: 5 · 2015: 14 · 2014: 16 · 2013: 16 · 2012: 13
FWCI
8.81
Type
journal article
Language
en
Open access
Locations
  • Blood (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • VUBIR (Vrije Universiteit Brussel) (submittedVersion)
Funders
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK065029)
  • National Center for Research Resources (M01RR001346)
Topics
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
  • Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
  • Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
Keywords
hepcidin, multiple myeloma, anemia of chronic disease, BMP-2, iron regulation, interleukin-6, STAT3, serum cytokines, BMP4, BMP6, BMP9, noggin
MeSH terms
Anemia, Hemoglobins, Humans, Multiple Myeloma, Mutation, Promoter Regions, Genetic, Interleukin-6, Gene Expression Regulation, Neoplastic, Bone Morphogenetic Proteins, Antimicrobial Cationic Peptides, Cell Line, Tumor, STAT3 Transcription Factor, Bone Morphogenetic Protein 2, Hepcidins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2. https://app.cochat.ai/papers/10.1182/blood-2010-03-274571
The paper
Maes, K., Nemeth, E., Roodman, G. D., Huston, A., Esteve, F., Freytes, C., Callander, N., Katodritou, E., Tussing-Humphreys, L., Rivera, S., Vanderkerken, K., Lichtenstein, A., & Ganz, T. (2010). In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2. Blood. https://doi.org/10.1182/blood-2010-03-274571

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.